TELO Telomir Pharmaceuticals

Watchlist

Trading Dec 12 10:30 ET

151.60MMarket Cap-6.61P/E (TTM)

Telomir Pharmaceuticals Key Stats

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--------

Unlock Free Earnings Estimates

Open Account

Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12 16:50 ET

Telomir Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 13 16:09 ET

Telomir Pharmaceuticals | 10-Q: Quarterly report

May 13 16:36 ET

Telomir Pharmaceuticals | 10-K: FY2023 Annual Report

Mar 29 17:33 ET

Overall

No Data